|
EVERSANA: Partnering & Licensing.
|
3
|
Resverlogix Corp.
|
Jul 15, 2021 12:18PM
|
|
Bayer and the CKD space we wanted to dominate in.
|
3
|
Resverlogix Corp.
|
Oct 25, 2020 02:17AM
|
|
So, we have a consultant.
|
3
|
Resverlogix Corp.
|
Sep 29, 2021 12:04PM
|
|
Re: "So if you get fantastic results in a Brazilian COVID-19 clinical trial, be prepared..." is my read.
|
3
|
Resverlogix Corp.
|
Aug 02, 2021 03:09PM
|
|
CTO is here to help move forward COVID-19 studies as quickly as possible.
|
3
|
Resverlogix Corp.
|
Jul 15, 2021 12:41PM
|
|
Re: Merck’s pill
|
3
|
Resverlogix Corp.
|
Oct 07, 2021 02:48PM
|
|
Re: Question for posters
|
3
|
Resverlogix Corp.
|
Dec 11, 2021 03:21PM
|
|
Re: Apabetalone for Pulmonary Arterial Hypertension (APPROACH-2).
|
3
|
Resverlogix Corp.
|
Aug 24, 2021 03:00PM
|
|
SO078 APABETALONE, A BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES ALKALINE PHOSPHATASE IN CVD PATIENTS....
|
3
|
Resverlogix Corp.
|
May 02, 2020 11:35PM
|
|
Just brutal!
|
3
|
Resverlogix Corp.
|
Mar 14, 2022 07:16PM
|
|
Re: buy on rumour sell on news?
|
3
|
Resverlogix Corp.
|
Mar 01, 2021 07:56PM
|
|
Ontario becomes the first province to list fluvoxamine as a COVID-19 treatment to consider.
|
3
|
Resverlogix Corp.
|
Dec 22, 2021 11:45PM
|
|
"So if you get fantastic results in a Brazilian COVID-19 clinical trial, be prepared..." is my read.
|
3
|
Resverlogix Corp.
|
Jul 27, 2021 07:44AM
|
|
New treatment for COVID-19 discovered in human skin cells.
|
3
|
Resverlogix Corp.
|
Mar 11, 2022 02:11AM
|
|
As Pfizer charges ahead....
|
3
|
Resverlogix Corp.
|
Sep 03, 2021 12:39PM
|
|
"We have the vaccine, but we shouldn’t be resting on our laurels...."
|
3
|
Resverlogix Corp.
|
Jul 21, 2021 12:04PM
|
|
Those are some great stats, but unfortunately not ours.
|
3
|
Resverlogix Corp.
|
Jan 15, 2022 12:25PM
|
|
Re: News report on last NR
|
4
|
Resverlogix Corp.
|
Mar 05, 2021 11:44PM
|
|
Re: From six months ago
|
4
|
Resverlogix Corp.
|
Jun 17, 2021 11:51PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
4
|
Resverlogix Corp.
|
Apr 12, 2021 07:59PM
|
